Immunic, Inc.
IMUX
$0.7272
$0.01421.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -96.40M | -100.51M | -96.90M | -95.31M | -97.92M |
| Total Depreciation and Amortization | 151.00K | 134.00K | 122.00K | 114.00K | 105.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.56M | 15.22M | 14.56M | 14.33M | 14.88M |
| Change in Net Operating Assets | 6.11M | 386.00K | 6.39M | 8.52M | 7.65M |
| Cash from Operations | -82.57M | -84.77M | -75.83M | -72.34M | -75.28M |
| Capital Expenditure | -280.00K | -264.00K | -426.00K | -420.00K | -261.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | 4.36M |
| Cash from Investing | -280.00K | -264.00K | -426.00K | -420.00K | 4.10M |
| Total Debt Issued | 0.00 | 74.27M | 74.27M | 74.27M | 74.27M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 83.00K | 274.00K | 795.00K | 1.08M | 1.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.00K | -6.00K | -- | -- | -- |
| Cash from Financing | 77.00K | 74.54M | 75.07M | 75.35M | 75.45M |
| Foreign Exchange rate Adjustments | -232.00K | -517.00K | 570.00K | -187.00K | 293.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -83.01M | -11.01M | -618.00K | 2.40M | 4.55M |